Literature DB >> 17172981

Role of Janus kinase/signal transducer and activator of transcription pathway in regulation of expression and inflammation-promoting activity of high mobility group box protein 1 in rat peritoneal macrophages.

Hui Liu1, Yong-Ming Yao, Yan Yu, Ning Dong, Hui-Nan Yin, Zhi-Yong Sheng.   

Abstract

Signal transduction mechanism in the regulation of high mobility group box protein 1 (HMGB1) has not yet been well elucidated. Our data showed for the first time that Janus kinase-signal transduction and activator of transcription (JAK/STAT) pathway played a major role in the regulation of expression and inflammatory effect of HMGB1. The study was carried out in the following sequence. Firstly, the role of JAK/STAT pathway in the regulation of expression of HMGB1 was examined. After stimulation with 75 ng/mL LPS in vitro, significant increases in HMGB1 expression and prompt activation of JAK/STAT pathway were demonstrated in cultured macrophages. On the other hand, administration of AG490 (specific inhibitor for JAK2), fludarabine (specific inhibitor for STAT1) or rapamycin (specific inhibitor for STAT3) markedly suppressed HMGB1 expression. Secondly, the role of JAK/STAT pathway in the regulation of TNF-alpha expression induced by HMGB1 was examined. When macrophages were stimulated with 10 microg/mL HMGB1 in vitro, significant increases in TNF-alpha expression and prompt activation of JAK/STAT pathway were demonstrated, whereas inhibitors of JAK/STAT pathway significantly suppressed TNF-alpha expression. Taken together, our data strongly indicated that expression and inflammatory effect of HMGB1 could be mediated by JAK/STAT pathway and suggested a possible clinical strategy to control an inflammatory effect of HMGB1 in sepsis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17172981     DOI: 10.1097/01.shk.0000233197.40989.31

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  20 in total

1.  JAK2 inhibition prevents innate immune responses and rescues animals from sepsis.

Authors:  Geber Peña; Bolin Cai; Edwin A Deitch; Luis Ulloa
Journal:  J Mol Med (Berl)       Date:  2010-08       Impact factor: 4.599

2.  Unphosphorylated STAT3 modulates alpha 7 nicotinic receptor signaling and cytokine production in sepsis.

Authors:  Geber Peña; Bolin Cai; Jun Liu; Esmerij P van der Zanden; Edwin A Deitch; Wouter J de Jonge; Luis Ulloa
Journal:  Eur J Immunol       Date:  2010-09       Impact factor: 5.532

3.  Exogenous MSCs ameliorate hypoxia/reoxygenation injury in renal tubular epithelial cells through JAK/STAT signaling pathway-mediated regulation of HMGB1.

Authors:  Lei Zhang; Yan Wang; Junjie Ma; Xingqiang Lai; Jiali Fang; Guanghui Li; Lu Xu; Guanghui Pan; Zheng Chen
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

Review 4.  The Specific Roles of JAK/STAT Signaling Pathway in Sepsis.

Authors:  Bin Cai; Jian-ping Cai; Yu-long Luo; Cheng Chen; Sen Zhang
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

Review 5.  Signaling pathways and intervention therapies in sepsis.

Authors:  Yun-Yu Zhang; Bo-Tao Ning
Journal:  Signal Transduct Target Ther       Date:  2021-11-25

Review 6.  HMGB1 in health and disease.

Authors:  Rui Kang; Ruochan Chen; Qiuhong Zhang; Wen Hou; Sha Wu; Lizhi Cao; Jin Huang; Yan Yu; Xue-Gong Fan; Zhengwen Yan; Xiaofang Sun; Haichao Wang; Qingde Wang; Allan Tsung; Timothy R Billiar; Herbert J Zeh; Michael T Lotze; Daolin Tang
Journal:  Mol Aspects Med       Date:  2014-07-08

7.  Tyrosine kinase inhibitor tyrphostin AG490 retards chronic joint inflammation in mice.

Authors:  Valeriya Gyurkovska; Tsvetanka Stefanova; Petya Dimitrova; Svetla Danova; Rositsa Tropcheva; Nina Ivanovska
Journal:  Inflammation       Date:  2014-08       Impact factor: 4.092

8.  Activation of interleukin-6/STAT3 in rat cholangiocyte proliferation induced by lipopolysaccharide.

Authors:  Li-Ping Chen; Ming Cai; Qi-Hao Zhang; Zhou-Li Li; Ye-Yong Qian; Hong-Wei Bai; Xing Wei; Bing-Yi Shi; Jia-Hong Dong
Journal:  Dig Dis Sci       Date:  2008-07-23       Impact factor: 3.199

9.  Inhibition of zymosan-induced kidney dysfunction by tyrphostin AG-490.

Authors:  Petya Dimitrova; Valeriya Gyurkovska; Irina Shalova; Luciano Saso; Nina Ivanovska
Journal:  J Inflamm (Lond)       Date:  2009-05-05       Impact factor: 4.981

10.  Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting α7 nAChR and M4 mAChR and inhibiting JAK2/STAT3 pathway in rats.

Authors:  Weiwei Zhang; Qi Sun; Xiaoli Gao; Yimin Jiang; Runtao Li; Jia Ye
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.